ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea · Delayed Price · Currency is KRW 99,700
-11,200 (-10.10%)
Aug 21, 2026, 3:30 PM KST
ST Pharm Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, ST Pharm stock has a consensus rating of "Strong Buy" and an average price target of ₩180,000. The average 1-year stock price forecast is 80.54% higher than the current stock price, while the lowest is ₩140,000 (+40.42%) and the highest is ₩210,000 (+110.63%).
Price Target: ₩180,000 (+80.54%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for ST Pharm stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 7 | 6 | 6 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 11 | 10 | 10 |
Financial Forecast
Revenue This Year
419.97B
from 331.68B
Increased by 26.62%
Revenue Next Year
504.81B
from 419.97B
Increased by 20.20%
EPS This Year
3.33K
from 2.69K
Increased by 23.72%
EPS Next Year
4.36K
from 3.33K
Increased by 31.11%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.